Professor Risch Responds to Dr Rushworth over Hydroxychloroquine Post
Professor Harvey Risch responded today to a post by Sebastian Rushworth M.D., a physician in Stockholm, Sweden, who maintains a popular blog on C19. The
Professor Harvey Risch responded today to a post by Sebastian Rushworth M.D., a physician in Stockholm, Sweden, who maintains a popular blog on C19. The
Considering the burden on hospitals, the decision was made to treat the asymptomatic and mild cases at home and moderate and severe cases in the hospitals.
“We live in a strange post-truth world devoid of honest free speech, integrity, compassion & science.” — Professor Robert Clancy Selected Highlights both early treatment
This February 20, the IHU Marseille had as distinguished guest for a video conference: the prestigious Stanford Professor, John P.A. Ioannidis, MD, PhD The theme
This 30 min interview reviews the whereabouts of C19 treatments since the beginning of the pandemic, both at US and global levels, with emphasis on
This is a guest opinion by Dr Klaus Schustereder, a medical doctor specialized in general internal medicine, now working in Switzerland. Dr Schustereder has extensive
(Article also available in French) Foreword by Professor Peter A. McCullough This powerfully written, well researched, cogent summary of the principles of early ambulatory treatment
Avec la pandémie qui sévit dans de nombreux pays, la peur d’être hospitalisé est élevée. Les situations varient, mais le risque de décès à l’hôpital
With the pandemic raging in many countries, the fear to be hospitalized is high. Situations vary, but the risk of in hospital death from C19
Pour ceux qui suivent le développement des traitements préventifs et précoces du C19, un aspect étonnant est la répression quasi simultanée de l’information, en utilisant
On November 18, the Association of American Physicians and Surgeons released a “Guide to Home-Based COVID Treatment,” co-authored by Jane Orient, MD, Internal Medicine; Peter
Dans une mise à jour vidéo publiée aujourd’hui, le professeur Didier Raoult a indiqué avoir publié une copie d’une lettre de la société pharmaceutique SANOFI